trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride has been researched along with Cranial Nerve II Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charish, J; Farhani, N; Feng, J; Koeberle, PD; Monnier, PP; Mothe, AJ; Qin, X; Shabanzadeh, AP; Sugita, S; Tassew, NG; Wälchli, T | 1 |
1 other study(ies) available for trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Cholesterol synthesis inhibition promotes axonal regeneration in the injured central nervous system.
Topics: Animals; Anticholesteremic Agents; Axons; Cell Survival; Chick Embryo; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Membrane Microdomains; Membrane Proteins; Myelin Sheath; Nerve Regeneration; Neurons; Optic Nerve; Optic Nerve Injuries; Photoreceptor Cells; Prenylation; Prodrugs; Rats; Retina; Retinitis Pigmentosa; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 2021 |